Breast Cancer Research

US Patent Application 20130059018 A1, Mar 7, 2013 - Phytocannabinoids in the treatment of cancer

​

Disease Modification of Breast Cancer-Induced Bone Remodeling by Cannabinoid 2 Receptor Agonists

Lozano-Ondoua, Alysia, et al.

Journal of Bone and Mineral Research. 2012 Dec 18, 28(1): 92-107 (Full).

​

Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration

Takeda, Shuso, et al.

Toxicology Letters. 2012 Nov 15, 214(3): 314-319 (abstract).

​

Cannabinoids: A new hope for breast cancer therapy?

Caffarel, Maria M, et al.

Cancer Treatment Reviews. 2012 Nov, 38(7): 911-918 (abstract).

​

Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy

Shrivastava, Ashutosh, et al.

Molecular Cancer Therapeutics. 2011, 10: 1161-1172 (Full).

​

Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion

Nasser, Mohd W, et al.

PLoS ONE. 2011 Sep, 6(9) (Full online article).

​

Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis

McAllister, Sean D, et al.

Breast Cancer Research and Treatment. 2011 Aug, 129(1): 37-47 (abstract).

​

Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer

Qamri, Zahida, et al.

Molecular Cancer Therapeutics. 2009 Nov 3, 8: 3117-3129 (Full).

​

JunD is involved in the antiproliferative effect of Δ9-tetrahydrocannabinol on human breast cancer cells

Caffarel, M M, et al.

Oncogene. 2008, 27: 5033-5044 (Full).

​

Delta(9)-tetrahydrocannabinol Inhibits 17β-Estradiol-induced Proliferation and Fails to Activate Androgen and Estrogen Receptors in MCF7 Human Breast Cancer Cells

Von Bueren, A.O., et al.

Anticancer Research. 2008, 28: 85-90 (Full).

​

Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells

McAllister, Sean D, et al.

Molecular Cancer Therapeutics. 2007, 6: 2921-2927 (Full).

​

Δ9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation

Caffarel, Maria M, et al.

Cancer Research. 2006 Jul 1, 66: 6615-6621 (Full).

​

Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells

Laezza, Chiara, et al.

FEBS Letters. 2006 Nov 13, 580(26): 6076-6082 (Full).

​

Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma

Ligresti, Alessia, et al.

The Journal of Pharmacology and Experimental Therapeutics. 2006, 318(3): 1375-1387 (Full).

​

Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation

Melck, Dominique, et al.

Endocrinology. 2000, 141(1): 118-126 (Full).

​

Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells

Melck, Dominique, et al.

FEBS Letters. 1999 Dec 17, 463(3): 235-240 (Full).

​

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation

De Petrocellis, Luciano, et al.

Proceedings of the National Academy Sciences of the United States of America. 1998 Jul 7, 95(14): 8375-8380 (Full).